Preoperative determination of fibrin degradation products (FDP) in the sera of patients with suspected gynecologic tumors
Andersen, H.J.; Marushak, A.
Ugeskrift for Laeger 147(21): 1689-1691
1985
ISSN/ISBN: 0041-5782 PMID: 4024309 Document Number: 241944
Document emailed within 1 workday
Related Documents
Vorlová, Z.; Dyr, I.E. 1979: Effect of fibrin-fibrinogenolysis on the determination of the fibrinogen content and fibrin-fibrinogen degradation products (FDP) by means of the fibrin polymerization time (FPT test) Folia Haematologica 106(5-6): 967-970Sørensen, M.D.; Ott, P.; Gad, I.; Gyhrs, S.; Iversen, D.; Treufeldt, P. 1988: Fibrin and fibrinogen degradation products in suspected deep venous thrombosis of the lower extremities Ugeskrift for Laeger 150(1): 20-22
Sumner, K.; Feller, E.; Galanakis, D.K.; Mosesson, M.W. 1979: Evaluation of two new assays for determination of serum fibrinogen/fibrin degradation products Annals of Clinical and Laboratory Science 9(5): 362-367
Lederman, S.; Rimon, A. 1975: Quantitative determination of fibrinogen-fibrin degradation products by viro-immunoassay Israel Journal of Medical Sciences 11(12): 1395
André, E.; Kessler, M.; Briquel, M.E.; Alexandre, P.; Hurault de Ligny, B.; Huriet, C. 1983: Practical interest of the determination of urinary fibrin degradation products in the early monitoring of kidney transplants Pathologie-Biologie 31(1): 23-27
Orbetsov, M.; Milanov, S.; Stankusheva, G.; Sheĭretova, E.; Atanasov, I. 1986: Early diagnosis of myocardial infarct. the determination of myoglobin and fibrin-degradation products in the blood serum Vutreshni Bolesti 25(2): 39-44
Solov'ev, A.V.; Ermolin, G.A.; Ignashenkova, G.V.; Dikov, M.M. 1987: Fibrinogen and fibrin degradation products in the blood of acute myocardial infarct patients at the hospital rehabilitation stage Terapevticheskii Arkhiv 59(10): 21-23
Kuroso, K.; Fujimaki, M. 1989: Fibrin/fibrinogen degradation products (FDP) Nihon Rinsho. Japanese Journal of Clinical Medicine 48 Suppl: 892-895
Fujimaki, M.; Ikematsu, S.; Kato, M. 1973: Fibrinogen and fibrin degradation products Rinsho Byori. Japanese Journal of Clinical Pathology 21(1): 31-36
Tomura, S.; Ideura, T.; Ida, T.; Osaka, Y.; Kuriyama, R.; Abe, T.; Takeuchi, J. 1979: Renal vein fibrin degradation products (FDP's) in glomerulonephritis Clinical Nephrology 12(6): 248-253
Khristov, V.; Apostolov, P.; Stamenova, T. 1979: Fibrin degradation products in the urine in diabetic nephropathy Vutreshni Bolesti 18(4): 32-36
Pstruzinová, H.; Rovenská, A.; Goderová, Z.; Kristan, M. 1980: Examination of fibrin degradation products in cirrhosis of liver Casopis Lekaru Ceskych 119(1): 7-11
Madoiwa, S. 2011: Cross-linked fibrin degradation products by leukocyte elastase (e-XDP) Rinsho Byori. Japanese Journal of Clinical Pathology Suppl 147: 65-70
Sen, D.K.; Sarin, G.S. 1981: Assay of fibrin degradation products in human aqueous humour Indian Journal of Ophthalmology 29(2): 87-89
Svanberg, L.; Astedt, B.; Gynning, I.; Nilsson, I.M. 1973: Fibrin degradation products during postoperative radiotherapy of ovarian carcinoma Acta Obstetricia et Gynecologica Scandinavica 52(2): 141-145
Schifreen, R.S.; Cembrowski, G.S.; Campbell, D.C.; Craig, A.R.; Demyanovich, N.D.; Jurga-Hall, P.A.; Reider, M.C.; Schwartz, M.W.; Tuhy, P.M.; Waller, S.J. 1985: A quantitative automated immunoassay for fibrinogen/fibrin degradation products Clinical Chemistry 31(9): 1468-1473
Weise, M.; Schwabe, G.; Neubüser, D. 1979: Fibrin and fibrinogen degradation products and other urinary proteins during eclampsia Minerva Medica 70(43): 2945-2949
Isobe, J.; Hamai, Y.; Taharaguchi, T.; Watanabe, H.; Kusumoto, M.; Saito, S. 1977: Studies on latex agglutination test for fibrin degradation products Rinsho Byori. Japanese Journal of Clinical Pathology 25(10): 843-847
Sasinka, M.; Plenta, I.; Páleníková, O.; Pavlovic, M.; Getlík, A.; Kaiserová, E. 1979: Analysis of fibrin-degradation products in the diagnosis of glomerulonephritis in children Ceskoslovenska Pediatrie 34(4): 202-204
Carroll, R.C.; Lockhart, M.S.; Taylor, F.B. 1984: Effect of crosslinking on the structure of solubilized fibrin degradation products in whole plasma Journal of Laboratory and Clinical Medicine 103(5): 695-703